ArticleCurrent oncology (Toronto, Ont.)2025
Real-World Clinical Outcomes of Trilaciclib for the Prevention of Myelosuppression in Patients with Esophageal Cancer Undergoing Chemotherapy.
Hui Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.